Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Bristol-Myers Squibb buy Daiwa Capital Markets

Start price
€59.00
28.06.23 / 50%
Target price
€64.04
28.06.24
Performance (%)
-33.56%
End price
€39.20
29.06.24
Summary
This prediction ended on 29.06.24 with a price of €39.20. Massive losses of -33.56% were the result for the BUY prediction by Daiwa_Capital_Market. Dividends of €2.16 are taken into consideration when calculating the performance. Daiwa_Capital_Market has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Bristol-Myers Squibb 4.856% 4.856% -31.916%
iShares Core DAX® -0.116% 1.953% 14.155%
iShares Nasdaq 100 -2.733% -1.273% 31.828%
iShares Nikkei 225® -1.721% 3.263% 12.922%
iShares S&P 500 -1.527% 0.194% 27.117%

Comments by Daiwa_Capital_Market for this prediction

In the thread Bristol-Myers Squibb diskutieren
Prediction Buy
Perf. (%) -33.56%
Target price 64.043
Change
Ends at 28.06.24

Bristol-Myers Squibb (NYSE: BMY) is now covered by analysts at Daiwa Capital Markets. They set an "outperform" rating and a $70.00 price target on the stock.
Ratings data for BMY provided by MarketBeat

In the thread Trading Bristol-Myers Squibb
Prediction Buy
Perf. (%) -33.56%
Target price 64.043
Change
Ends at 28.06.24

Die von Daiwa_Capital_Market gewählte maximale Laufzeit wurde überschritten